151 related articles for article (PubMed ID: 487086)
1. Immune lesions of central noradrenergic neurons produced by antibodies to dopamine-beta-hydroxylase.
Costa M; Geffen LB; Rush RA; Bridges D; Blessing WW; Heath JW
Brain Res; 1979 Sep; 173(1):65-78. PubMed ID: 487086
[TBL] [Abstract][Full Text] [Related]
2. Specific uptake and retrograde flow of antibody to dopamine-beta-hydroxylase by central nervous system noradrenergic neurons in vivo.
Silver MA; Jacobowitz DM
Brain Res; 1979 May; 167(1):65-75. PubMed ID: 88246
[TBL] [Abstract][Full Text] [Related]
3. The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker.
Swanson LW; Hartman BK
J Comp Neurol; 1975 Oct; 163(4):467-505. PubMed ID: 1100685
[TBL] [Abstract][Full Text] [Related]
4. Immune lesions of noradrenergic neurones in rat central nervous system produced by antibodies to dopamine-beta-hydroxylase.
Blessing WW; Costa M; Geffen LB; Rush RA; Fink G
Nature; 1977 May; 267(5609):368-9. PubMed ID: 865635
[No Abstract] [Full Text] [Related]
5. Involvement of complement in degeneration of sympathetic nerves after administration of antiserum to dopamine beta-hydroxylase.
Furness JB; Lewis SY; Rush R; Costa M; Geffen LB
Brain Res; 1977 Nov; 136(1):67-75. PubMed ID: 589447
[TBL] [Abstract][Full Text] [Related]
6. Origins of spinal noradrenergic pathways demonstrated by retrograde transport of antibody to dopamine-beta-hydroxylase.
Westlund KN; Bowker RM; Ziegler MG; Coulter JD
Neurosci Lett; 1981 Sep; 25(3):243-9. PubMed ID: 6170028
[TBL] [Abstract][Full Text] [Related]
7. Regional development of norepinephrine, dopamine-beta-hydroxylase and tyrosine hydroxylase in the rat brain subsequent to neonatal treatment with subcutaneous 6-hydroxydopamine.
Schmidt RH; Bhatnagar RK
Brain Res; 1979 Apr; 166(2):293-308. PubMed ID: 34468
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals.
Fritschy JM; Grzanna R
Neuroscience; 1989; 30(1):181-97. PubMed ID: 2747911
[TBL] [Abstract][Full Text] [Related]
9. Noradrenergic projections to the spinal cord of the rat.
Westlund KN; Bowker RM; Ziegler MG; Coulter JD
Brain Res; 1983 Mar; 263(1):15-31. PubMed ID: 6839168
[TBL] [Abstract][Full Text] [Related]
10. Origins and terminations of descending noradrenergic projections to the spinal cord of monkey.
Westlund KN; Bowker RM; Ziegler MG; Coulter JD
Brain Res; 1984 Jan; 292(1):1-16. PubMed ID: 6365245
[TBL] [Abstract][Full Text] [Related]
11. Noradrenergic system in the chicken brain: immunocytochemical study with antibodies to noradrenaline and dopamine-beta-hydroxylase.
Moons L; D'Hondt E; Pijcke K; Vandesande F
J Comp Neurol; 1995 Sep; 360(2):331-48. PubMed ID: 8522651
[TBL] [Abstract][Full Text] [Related]
12. Selective lesion of the developing central noradrenergic system: short- and long-term effects and reinnervation by noradrenergic-rich tissue grafts.
Coradazzi M; Gulino R; Garozzo S; Leanza G
J Neurochem; 2010 Aug; 114(3):761-71. PubMed ID: 20477936
[TBL] [Abstract][Full Text] [Related]
13. Rat medulla oblongata. II. Dopaminergic, noradrenergic (A1 and A2) and adrenergic neurons, nerve fibers, and presumptive terminal processes.
Kalia M; Fuxe K; Goldstein M
J Comp Neurol; 1985 Mar; 233(3):308-32. PubMed ID: 2858497
[TBL] [Abstract][Full Text] [Related]
14. Non-dopaminergic catecholaminergic neurons of mesencephalic and medullary nuclei contain different levels of dopamine.
Alonso G; Brun O; Ridet JL; Geffard M; Chauvet N
J Chem Neuroanat; 1995 Oct; 9(3):195-205. PubMed ID: 8588834
[TBL] [Abstract][Full Text] [Related]
15. The response of noradrenergic axons to systemically administered DSP-4 in the rat: an immunohistochemical study using antibodies to noradrenaline and dopamine-beta-hydroxylase.
Fritschy JM; Geffard M; Grzanna R
J Chem Neuroanat; 1990; 3(4):309-21. PubMed ID: 2204356
[TBL] [Abstract][Full Text] [Related]
16. Reversible changes in the accumulation and activities of tyrosine hydroxylase and dopamine-beta-hydroxylase in neurons of nucleus locus coeruleus during the retrograde reaction.
Ross RA; Joh TH; Reis DJ
Brain Res; 1975 Jul; 92(1):57-72. PubMed ID: 240484
[TBL] [Abstract][Full Text] [Related]
17. Retrograde transport of dopamine beta-hydroxylase antibodies in sympathetic neurons: effects of drugs modifying noradrenergic transmission.
Lees GJ; Horsburgh RJ
Brain Res; 1984 Jun; 301(2):281-6. PubMed ID: 6203610
[TBL] [Abstract][Full Text] [Related]
18. Projections of ventromedial hypothalamic neurons to the midbrain central gray: an ultrastructural study.
Chung SK; Pfaff DW; Cohen RS
Neuroscience; 1990; 38(2):395-407. PubMed ID: 2175855
[TBL] [Abstract][Full Text] [Related]
19. Restoration of ascending noradrenergic projections by residual locus coeruleus neurons: compensatory response to neurotoxin-induced cell death in the adult rat brain.
Fritschy JM; Grzanna R
J Comp Neurol; 1992 Jul; 321(3):421-41. PubMed ID: 1506478
[TBL] [Abstract][Full Text] [Related]
20. The use of dopamine -hydroxylase as a marker for the central noradrenergic nervous system in rat brain.
Hartman BK; Zide D; Udenfriend S
Proc Natl Acad Sci U S A; 1972 Sep; 69(9):2722-6. PubMed ID: 4560699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
